학술논문

1186P Impact of temozolomide (TEM) and capecitabine (CAP) dose reductions in toxicity and efficacy in patients (pts) with neuroendocrine neoplasms (NENs) treated with CAPTEM chemotherapy
Document Type
Abstract
Source
In Annals of Oncology September 2020 31 Supplement 4:S782-S782
Subject
Language
ISSN
0923-7534